Spero Therapeutics, Inc. (SPRO) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to earnings of $0.02 per share a year ago. These ...
The Spero-QT is the next breakthrough in label-free chemical imaging and represents the second generation of high-performance infrared microscopes powered by quantum cascade laser (QCL ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback